The Digest: April 2025
In this month's news, a flurry of 510(k) clearances (and one De Novo) and major M&A plays by Viscogliosi Brothers, Zydus Lifesciences, and more.
MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest IssueIn this month's news, a flurry of 510(k) clearances (and one De Novo) and major M&A plays by Viscogliosi Brothers, Zydus Lifesciences, and more.
Vascular neurosurgeon Luis Savastano brings a unique perspective to device invention as he straddles the surgical and endovascular worlds. While practicing medicine, he spends equal time on translational medicine. His unique set of skills led him to found Endovascular Engineering and Endovascular Horizons.
We present selected private financings for February and March and this month's VC snapshot features early-stage medtech investor Nina Capital.